Why BioNTech Stock Soared 66% in March While the Market Plunged
Shares of German clinical-stage biotech BioNTech (NASDAQ: BNTX) skyrocketed 66.4% in March, according to data from S&P Global Market Intelligence.
For context, last month the S&P 500 index returned negative 12.4%. The market sell-off is being driven by the coronavirus pandemic, which is in the early stages of negatively affecting the U.S. and world economies.
(This month, BioNTech stock has sunk 15.8% through April 6, compared to the broader market's 1.5% gain.)
Source Fool.com
